savolitinib

AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug
Endpoints
Mon, 08/8/22 - 09:54 am
AstraZeneca
Hutchmed
clinical trials
Tagrisso
savolitinib
lung cancer
AstraZeneca dumps phase 3 renal cell carcinoma program
Fierce Biotech
Thu, 10/24/19 - 10:23 am
AstraZeneca
savolitinib
renal cell carcinoma
Chi-Med, AstraZeneca's savolitinib helps some Tagrisso-resistant EGFR lung cancer patients
Fierce Pharma
Sun, 03/31/19 - 03:44 pm
Chi-Med
savolitinib
AstraZeneca
Tagrisso
EGFR lung cancer